Caxton Associates (UK)’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.46M Buy
8,720
+3,074
+54% +$875K 0.07% 136
2026
Q1
$979K Buy
+5,646
New +$1.16M 0.02% 383
2025
Q2
Sell
-1,577
Closed -$417K 783
2025
Q1
$417K Buy
+1,577
New +$427K 0.01% 540

Other funds holding HUM

Caxton Associates (UK)'s HUM Position: Q2 2026 in Review

Caxton Associates (UK) increased its Humana (HUM) stake by 54% in Q2 2026, buying an estimated $875K and bringing the position to 8,720 shares worth $3.46M. The position accounts for 0.07% of the portfolio, ranked #136.

Caxton Associates (UK) first reported a position in HUM in Q1 2025 and has held it in 3 quarters since. 924 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Caxton Associates (UK) held 8,720 shares of Humana worth $3.46M as of Q2 2026.
  • Caxton Associates (UK) bought 3,074 Humana shares in Q2 2026, an estimated $875K.
  • Humana made up 0.07% of Caxton Associates (UK)'s portfolio in Q2 2026, its #136 holding.
  • Caxton Associates (UK) first reported a position in Humana in Q1 2025 and has held it in 3 quarters since.
  • 924 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.